லாகேச் கூட்டாளிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லாகேச் கூட்டாளிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லாகேச் கூட்டாளிகள் Today - Breaking & Trending Today

Cytek Biosciences Announces Pricing of Its Initial Public Offering


Share:
FREMONT, Calif., July 22, 2021 (GLOBE NEWSWIRE) Cytek Biosciences, Inc. ( Cytek Biosciences or Cytek ) (NASDAQ:CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds to Cytek from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $200 million. Cytek is offering 11,764,706 shares of common stock and the selling stockholders named in the prospectus are offering 2,799,929 shares of common stock. Cytek will not receive any proceeds from the sale of shares by the selling stockholders. In addition, Cytek has granted the underwriters a 30-day option to purchase up to an additional 2,184,695 shares of common stock solely to cover over-allotments, if any, at the initial public offering price, less underwriting discounts and commi ....

United States , New York , Stephanie Olsen , Cytek Biosciences , Morgan Stanley , Broadridge Financial Solutions , Lages Associates , Exchange Commission , Prospectus Department , Cytek Biosciences Inc , European Union , Gilmartin Group , Piper Sandler Co , Goldman Sachs Co , Morgan Stanley Co , Nasdaq Global Select Market , Goldman Sachs , Piper Sandler , Island Avenue , Full Spectrum Profiling , Northern Lights , Relations Contact , ஒன்றுபட்டது மாநிலங்களில் , புதியது யார்க் , மாற்றாந்தாய் ஓல்‌ஸெந் , மோர்கன் ஸ்டான்லி ,

Cytek Biosciences Announces Pricing of Its Initial Public


Cytek Biosciences Announces Pricing of Its Initial Public Offering
July 22, 2021 22:43 ET
| Source:
Cytek Biosciences, Inc.
Cytek Biosciences, Inc.
Fremont, California, UNITED STATES
FREMONT, Calif., July 22, 2021 (GLOBE NEWSWIRE) Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds to Cytek from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be $200 million. Cytek is offering 11,764,706 shares of common stock and the selling stockholders named in the prospectus are offering 2,799,929 shares of common stock. Cytek will not receive any proceeds from the sale of shares by the selling stockh ....

United States , New York , Stephanie Olsen , Cytek Biosciences , Morgan Stanley , Broadridge Financial Solutions , Lages Associates , Exchange Commission , Prospectus Department , Cytek Biosciences Inc , European Union , Gilmartin Group , Piper Sandler Co , Goldman Sachs Co , Morgan Stanley Co , Nasdaq Global Select Market , Goldman Sachs , Piper Sandler , Island Avenue , Full Spectrum Profiling , Northern Lights , Relations Contact , ஒன்றுபட்டது மாநிலங்களில் , புதியது யார்க் , மாற்றாந்தாய் ஓல்‌ஸெந் , மோர்கன் ஸ்டான்லி ,

Cytek® Biosciences Appoints Allen Poirson as Senior Vice President of Marketing and Corporate Development


Cytek® Biosciences Appoints Allen Poirson as Senior Vice President of Marketing and Corporate Development
Biotech Industry Veteran Tapped to Support Growing Momentum
April 28, 2021 10:00 ET
| Source:
Cytek Biosciences
Cytek Biosciences
Fremont, California, UNITED STATES
FREMONT, Calif., April 28, 2021 (GLOBE NEWSWIRE) Cytek Biosciences, Inc., a leading life sciences technology company, today announced that Allen Poirson, Ph.D. has been appointed as the senior vice president of marketing and corporate development for the company. In this role, Poirson will head Cytek’s marketing department and lead the company’s continued growth strategy, including through potential partnerships and strategic investments in complementary businesses, services, products or technologies. The addition of Poirson to the management team comes at a time when an ever-increasing number of labs around the world are embracing ....

Stanford University , United States , Allen Poirson , Wenbin Jiang , Stephanie Olsen , Cytek Aurora , Cytek Biosciences , Cytek Biosciences Inc , European Union , Lages Associates , Xar Pharmaceuticals , Howard Hughes Medical Institute , Accuimage Diagnostics , Mighty Capital , Full Spectrum Profiling , Northern Lights , ஸ்டான்போர்ட் பல்கலைக்கழகம் , ஒன்றுபட்டது மாநிலங்களில் , மாற்றாந்தாய் ஓல்‌ஸெந் , ஐரோப்பிய தொழிற்சங்கம் , லாகேச் கூட்டாளிகள் , ஹோவர்ட் ஹக்ஸ் மருத்துவ நிறுவனம் , வலிமைமிக்க மூலதனம் , வடக்கு விளக்குகள் ,